• Explore /
  • Poster
  • / Association of immune markers and Immunoscore with survival of stage III colon carcinoma (CC) patients (pts) treated with adjuvant FOLFOX: NCCTG N0147 (Alliance).

Association of immune markers and Immunoscore with survival of stage III colon carcinoma (CC) patients (pts) treated with adjuvant FOLFOX: NCCTG N0147 (Alliance).

Abstract Poster

Authors

null

Frank A. Sinicrope

Mayo Clinic, Rochester, MN

Frank A. Sinicrope , Qian Shi , Fabienne Hermitte , Erica N Heying , Al Bowen Benson III, Sharlene Gill , Richard M. Goldberg , Morton S. Kahlenberg , Suresh Nair , Anthony Frank Shields , Daniel J. Sargent , Jerome Galon , Steven R. Alberts

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Colorectal) Cancer

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Epidemiology/Outcomes

Clinical Trial Registration Number

NCT00079274

Citation

J Clin Oncol 35, 2017 (suppl; abstr 3579)

DOI

10.1200/JCO.2017.35.15_suppl.3579

Abstract #

3579

Poster Bd #

202

Abstract Disclosures

Similar Posters

First Author: Bahar Saberzadeh Ardestani

First Author: Frank A. Sinicrope

First Author: Aziz Zaanan

First Author: Cynthia Reichling